Rosuliv f

Rosuliv F Tablets contain a combination of Rosuvastatin I.P. 10 mg and Fenofibrate I.P. 160 mg. This powerful combination is used to manage mixed dyslipidemia by lowering bad cholesterol (LDL), triglycerides, and increasing good cholesterol (HDL). It works by reducing cholesterol production in the liver and enhancing fat metabolism, thereby supporting overall cardiovascular health and reducing the risk of heart-related diseases.

Key Benefits

• Reduces bad cholesterol (LDL) levels
• Lowers triglycerides effectively
• Increases good cholesterol (HDL)
• Helps prevent heart disease and stroke
• Improves overall lipid profile

Key Ingredients

• Rosuvastatin I.P. 10 mg – A statin that reduces cholesterol production in the liver
• Fenofibrate I.P. 160 mg – Helps break down triglycerides and improve lipid metabolism

Indications

• Mixed dyslipidemia
• High cholesterol and triglycerides
• Hyperlipidemia
• Cardiovascular risk reduction
• Prevention of heart attack and stroke

Dosage

• As directed by a physician
• Usually taken once daily, with or without food
• Follow prescribed diet and exercise for best results

Precautions

• Use only under medical supervision
• Regular liver function monitoring is recommended
• Inform your doctor if you have liver, kidney, or muscle disorders
• May cause side effects like muscle pain, weakness, or gastrointestinal discomfort
• Avoid alcohol consumption during treatment
• Not recommended during pregnancy or breastfeeding
• Store in a cool and dry place
• Keep out of reach of children

Common side effects may include headache, muscle pain, joint pain, nausea, abdominal discomfort, and elevated liver enzymes. Rare but serious side effects include myopathy, rhabdomyolysis, and pancreatitis, particularly when statins and fibrates are used together. Patients should be advised to report any signs of muscle tenderness, weakness, or dark-colored urine. Liver function and creatine kinase levels should be monitored periodically. Gastrointestinal disturbances or skin rash may also occur in some individuals.

Rosuliv f 10 Tablet is indicated for the treatment of mixed dyslipidemia and severe hypertriglyceridemia in patients who require both LDL-C and triglyceride reduction. It is also prescribed to patients with cardiovascular risk factors, such as diabetes, hypertension, or a family history of heart disease, especially when monotherapy has proven insufficient.

Rosuliv f 10 should be used under the guidance of a healthcare professional. It is contraindicated in patients with active liver disease, gallbladder disorders, severe kidney impairment, or known hypersensitivity to any of its components. The combination therapy increases the risk of muscle toxicity, particularly in elderly individuals or those with existing renal dysfunction. Alcohol should be avoided or minimized. This medication should not be used during pregnancy or breastfeeding. A lipid-lowering diet, regular physical activity, and routine laboratory monitoring are important to ensure safe and effective therapy.

Store Rosuliv f 10 Tablet in a cool and dry place, preferably below 30°C. Protect the medication from moisture and direct sunlight. Keep out of reach of children. Do not use the medicine after its expiry date.